| 产品详情 |
| Edit |   |
|---|
| Product Name | 4-(6-Nitro-3-pyridinyl)-1-piperazine-2,2,6,6-d4-carboxylic Acid 1,1-Dimethylethyl Ester |
|---|
| Description | 4-(6-Nitro-3-pyridinyl)-1-piperazine-2,2,6,6-d4-carboxylic Acid 1,1-Dimethylethyl Ester is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular Formula: C14H16D4N4O4 Solubility: Dichloromethane; Ethyl Acetate; Methanol Molecular Weight: 312.36 |
|---|
| Size | 25mg, 50mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 429311 |
|---|
| Price | |
|---|
| Order / More Info | 4-(6-Nitro-3-pyridinyl)-1-piperazine-2,2,6,6-d4-carboxylic Acid 1,1-Dimethylethyl Ester from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|